| abstract |
The present invention relates to an aryl-containing 5-acylindolinone of the general formula (I) (Wherein R 1 to R 3 are as defined in claims 1 to 7), tautomers, enantiomers, diastereomers, mixtures and salts thereof, all of which have beneficial pharmacological properties, In particular, it has an inhibitory effect on protein kinase, particularly an inhibitory effect on the activity of glycogen synthase kinase (GSK-3). [Selection figure] None |